Clinical Trial Update: A Two-armed Real-world Study of Ozempic (OW Semaglutide) to Evaluate Its Adherence and Persistence Compared With Other Anti-diabetic Drugs Among Adult T2DM Patients in China

View source ↗

Summary

A real-world, two-armed study in China will compare adherence and persistence of Ozempic (semaglutide) with other anti-diabetic drugs in adults with type 2 diab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• OZEMPIC (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Type 2 Diabetes | Status: NOT_YET_RECRUITING